Spyre Therapeutics, Inc. $SYRE Shares Bought by B Group Inc.

B Group Inc. increased its holdings in Spyre Therapeutics, Inc. (NASDAQ: SYRE) by 25.0% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 100,000 shares of the company's stock after buying an additional 20,000 shares during the period. Spyre Therapeutics comprises approximately 1.3% of B